A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

An old anti-seizure drug might also work to reduce apnea episodes, recent trial data has shown. Millions of people in the U.S ...

Right-size your expectations.

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

A causal link is plausible, researchers say ...

Custom-fitted oral appliances reduce airway obstruction by physically repositioning the lower jaw or tongue forward during sleep. While CPAP machines generally lower the apnea-hypopnea index more ...

A nerve stimulator implant called Inspire is helping some sleep apnea patients breathe normally at night when a CPAP machine is not an effective treatment.

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

A new study finds that having obstructive sleep apnea increases the risk that a person will eventually develop Parkinson’s disease, and the more severe the apnea, the higher the risk. CPAP therapy ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...